$RNN Recent News Rexahn prices offering at 30% discount

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
$RNN Recent News

Rexahn prices offering at 30% discount 10:58 a.m. Nov. 29, 2012 - MarketWatch.com
AEterna falls; Inspire, Rexahn rally 2:15 p.m. April 16, 2010 - Val Brickates Kennedy
Javelin rockets, Myriad gains on scrapped merger 12:20 p.m. April 12, 2010 - Val Brickates Kennedy
Wednesday's biggest gaining and declining stocks 3:26 p.m. April 7, 2010 - MarketWatch
Rexahn, Avanir gain; Sequenom falls 12:32 p.m. April 7, 2010 - Val Brickates Kennedy
Letter up 230% last year without trading 3:00 a.m. Jan. 11, 2010 - Peter Brimelow

Rexahn Pharmaceuticals (RNN) Jumps: Stock Up 5.3% - Tale of the Tape 9:39 a.m. Jan. 27, 2014 - Zacks.com
It's Hard to Believe, but Biotech Stocks Are Starting 2014 Hotter Than 2013 7:00 a.m. Jan. 21, 2014 - TheStreet.com
Rexahn Pharmaceutical Shares Are Still A Buy Despite Recent Volatility 3:38 p.m. Jan. 15, 2014 - Seeking Alpha
Rexahn Pharma slides after announcing offering 9:11 a.m. Jan. 15, 2014 - Seeking Alpha
3 Biotechs Getting Plenty Of Attention From Investors 8:26 a.m. Jan. 15, 2014 - Seeking Alpha
Morning Market Losers 9:02 a.m. Jan. 14, 2014 - benzinga.com
Morning Market Movers 8:55 a.m. Jan. 13, 2014 - benzinga.com
Why Rexahn Pharmaceuticals (RNN) Is Up Today 10:35 a.m. Jan. 10, 2014 - TheStreet.com
Rexahn up 15% after Buy rating 1:25 p.m. Jan. 9, 2014 - Seeking Alpha
Rexahn's Replacement For Eli Lilly's Gemzar Enters New Clinical Trial 12:20 p.m. Jan. 9, 2014 - Seeking Alpha
Rexahn: A Turn Around Story For 2014 12:49 p.m. Dec. 22, 2013 - Seeking Alpha
Rexahn's Akt-1 Inhibitor To Begin Phase II Trials For Kidney Treatment 1:47 p.m. Nov. 25, 2013 - Seeking Alpha
Rexahn's Recent Clinical Data Points To A New And Better Chemotherapy Pill 7:57 p.m. Oct. 6, 2013 - Seeking Alpha
Rexahn Pharmaceuticals Announces Publication of Preclinical Data for Novel Anti-Cancer Compound RX-3117 6:02 a.m. Sept. 30, 2013 - benzinga.com
Rexahn Regains Rights To Novel Cancer Drug As Teva Continues Its Pipeline Stumble 4:06 p.m. Sept. 5, 2013 - Seeking Alpha
Teva-Rexahn Deal Terminated - Analyst Blog 10:40 a.m. Aug. 30, 2013 - Zacks.com
10-Q: REXAHN PHARMACEUTICALS, INC. 3:15 p.m. Aug. 12, 2013 - Edgar Online - (EDG = 10Q, 10K)
Rexahn Pharmaceuticals Initiates Dosing in Phase I Trial of SupinoxinTM (RX-5902) a Candidate for Treating Solid Cancer Tumors 6:01 a.m. Aug. 7, 2013 - benzinga.com
Rexahn's CEO Uses A Business-Driven Cancer Model For Shareholder Value 5:34 p.m. Aug. 5, 2013 - Seeking Alpha
Rexahn Redesigns Cancer Superdrug Taxotere 12:58 p.m. July 18, 2013 - Seeking Alpha


Opening Buzzers: Chelsea Therapeutics International, Tesla Motors Inc, NQ Mobile Inc, Rexahn Pharmaceuticals 11:02 a.m. Jan. 15, 2014 - ACCESSWIRE
Rexahn Announces $20 Million Registered Direct Offering 8:59 a.m. Jan. 15, 2014 - BusinessWire - BZX
Rexahn Initiates Phase IIa Clinical Trial of Archexin® in Patients with Metastatic Renal Cell Carcinoma 9:00 a.m. Jan. 14, 2014 - BusinessWire - BZX
Rexahn Initiates Phase Ib Clinical Trial of RX-3117 for Treatment of Solid Tumors 8:00 a.m. Jan. 8, 2014 - BusinessWire
Rexahn Pharmaceuticals to Present at the Biotech Showcase 2014 8:00 a.m. Jan. 7, 2014 - BusinessWire
Rexahn Receives Method Patent for Treatment of Solid Tumor Cancers for Supinoxin (TM) (RX-5902) 8:17 a.m. Dec. 11, 2013 - BusinessWire
Rexahn Pharmaceuticals to Participate in Brean Capital 2013 Life Sciences Summit 8:00 a.m. Nov. 19, 2013 - BusinessWire
Rexahn Pharmaceuticals Reports Third Quarter Financial Results and Pipeline Update 8:00 a.m. Nov. 14, 2013 - BusinessWire
Rexahn Announces $5.3 Million At Market Registered Direct Offering 8:00 a.m. Oct. 11, 2013 - BusinessWire
Rexahn Pharmaceuticals In-Licenses Novel Oligonucleotide Targeted Drug Delivery Platform from Ohio State University 7:00 a.m. Oct. 10, 2013 - BusinessWire
Rexahn Pharmaceuticals Announces Publication of Preclinical Data for Novel Anti-Cancer Compound RX-3117 7:00 a.m. Sept. 30, 2013 - BusinessWire
Rexahn Awarded Patent in Europe for Cancer Drug Archexin(R) 7:00 a.m. Sept. 12, 2013 - BusinessWire
Rexahn Pharmaceuticals to Present at the 15th Annual Rodman & Renshaw Global Investment Conference on September 9, 2013 7:00 a.m. Sept. 5, 2013 - BusinessWire
Rexahn Pharmaceuticals Provides a Clinical Development and Financial Update 7:00 a.m. Sept. 4, 2013 - BusinessWire
Rexahn Pharmaceuticals Announces Teva will not Exercise its Option to License RX-3117 8:00 a.m. Aug. 28, 2013 - BusinessWire
Rexahn Pharmaceuticals Initiates Dosing in Phase I Trial of Supinoxin(TM) (RX-5902) a Candidate for Treating Solid Cancer Tumors 7:00 a.m. Aug. 7, 2013 - BusinessWire
University Of Maryland, Baltimore's Licensing Deals Fuel Local Life Sciences Community 7:30 a.m. Aug. 6, 2013 - PR Newswire
Rexahn Pharmaceuticals Announces $5.7 Million Registered Direct Offering 8:00 a.m. July 24, 2013 - BusinessWire
Rexahn Pharmaceuticals In-Licenses Breakthrough Oncology Drug Delivery Platform 7:00 a.m. July 17, 2013 - BusinessWire
Rexahn Pharmaceuticals Announce IND Submission for RX-3117 7:00 a.m. July 15, 2013 - BusinessWire

Scroll down for more posts ▼

Top 10 Most Recent News Articles

PJM Prepares to Tackle Winter Power Demands

Updated Category News Views 41

Eyeing the Season Ahead The chill in the air isn't just meteorological; there's a business note to notice every winter in PJM's sprawling territory. With power supplies robust yet stretched thin, PJM is bracing to navigate another demanding cold season. They’ve announced they have 182,426 MW of operational capacity nipping at the heels of a projected peak demand of...

Continue Reading
DTE's Strategic Shift: Vantage Sale and Green Goals

Updated Category News Views 83

You know, DTE Energy (NYSE: DTE) might just be playing the long game of twister with its assets. With their recent announcement to offload the non-utility business DTE Vantage for $3 billion, it's a clear signal they're doubling down on their core utility operations. This move isn't just some minor shuffle—it's a serious pivot aimed at honing every resource towards what...

Continue Reading
Omaha Steaks Reaches Milestone in Corporate Gifts

Updated Category News Views 65

Omaha Steaks Boosts Business Gifting Program If you've been around as long as I have, you know a good steak is worth its weight in gold, especially if it's Omaha Steaks we're talking about. Now, they're pushing the borders of their business gifting program to a whole new level, and it's pretty intriguing, if you ask me. Aiming to surpass the 5 million mark in corporate...

Continue Reading
Ast?'s Strategy: Scaling Brands with Operator Insight

Updated Category News Views 36

Defining the Investor-Entrepreneur Partnership Ah, building a consumer brand is no walk in the park, but what about scaling it? Here's where the rubber really meets the road. Enter Ast? Consumer Partners, a firm that clearly understands that scaling a brand isn't all about throwing cash at it—it’s about precision and the right mix of wisdom, much like a seasoned chef...

Continue Reading
NSING's Bluetooth Milestone: A Signal for Investors

Updated Category News Views 150

The Bluetooth Bonanza: NSING Technologies' Big Win Amidst the bustling lanes of the semiconductor sector, NSING Technologies just threw down a whopper of an announcement—over 250 million Bluetooth chips shipped, all well-knitted with Ceva's technology. This isn’t just another milestone; it's a clarion call for anyone keeping an eye on the evolving landscape of...

Continue Reading
Upright Proton Therapy: New Era for Cancer Care

Updated Category News Views 116

BayCare's Bold Step into Upright Proton Therapy Here's a twist for you—BayCare Health System has rolled out something that's genuinely pushing the envelope in cancer treatment. They've treated their first patient with an upright proton therapy system. Now, talk about innovation that shakes things up. This isn't just any old upgrade; it's a complete revamp of how proton...

Continue Reading
Tort Costs Weigh Heavily on U.S. Households in 2025

Updated Category News Views 17

Hidden Costs, Heavy Burdens Digging into the meat of these new figures makes you wonder how deep our pockets really go before they turn inside out. Here we are, facing the cold reality: U.S. tort litigation costs a whopping $655.6 billion in 2025, meaning each American household felt the sting of legal fees to the tune of over $4,900 annually. Yeah, you heard right—this...

Continue Reading
Global Leaders Unite to Tackle Major World Challenges

Updated Category News Views 119

Gathering Minds in Washington: A Summit to Remember Let me tell you straight – when over a hundred heavyweights from government, finance, and tech get in the same room, you bet people start paying attention. We’re talking about the 2026 WICE Global Impact Summit that went down at The Penthouse in The Washington Post Building. The movers and shakers weren't there to...

Continue Reading
Tigo Energy Faces Class Action Lawsuit for Securities Missteps

Updated Category News Views 95

Investor Caution: Tigo Energy's Legal Battle Well, looks like Tigo Energy, Inc. (NASDAQ: TYGO) is feeling the heat under regulatory scrutiny. This company's been slapped with a class action lawsuit over some mighty serious securities law violations. The DJS Law Group issued a reminder to investors about the lawsuit aimed at Tigo for messing with investors' heads via...

Continue Reading
Breeze Airways Secures $228M for Fleet Expansion

Updated Category News Views 93

Breeze Airways and AIP's Milestone Deal Just as the ink is drying on the balance sheets, Breeze Airways is busy making significant moves in the aviation game. Partnering with AIP Capital, they just locked in a $228 million secured debt facility to grab six new Airbus A220-300 aircraft. Now, that’s how you stake your claim in the market. What we’ve got here isn’t...

Continue Reading

Top 5 Most Recently Viewed Articles

Youth Seek Security in Civil Service Amid Economic Challenges

Updated Category News Views 246

Chinese Youth Turn to Civil Service for Stability The demand for civil service jobs among the youth in China has surged remarkably, with a staggering 3.4 million candidates registering for the civil service exam this year. This trend can be largely attributed to the allure of job security in the face of a struggling economy and rising youth unemployment rates. With...

Continue Reading
Crawler Dozers Market Growth Soars to USD 13.2 Billion

Updated Category News Views 202

Expanding Crawler Dozers Market and Its Drivers The crawler dozers market is experiencing dynamic growth, with estimates suggesting an increase from approximately USD 8.5 billion in a couple of years to a substantial USD 13.2 billion by 2034. This remarkable growth, attributed to a compound annual growth rate (CAGR) of 4.6%, reflects the increasing need for advanced...

Continue Reading
New Floating-Rate Bonds Initiative Enhancing Funding Solutions

Updated Category News Views 167

New Floating-Rate Bonds Initiative Enhancing Funding Solutions Realkredit Danmark is set to launch new mortgage covered bonds (SDRO) aimed at financing the RD Nibor3® and RD Stibor3® initiatives. This step marks a significant move in the company's efforts to enhance its funding solutions and refine existing financial structures. In an ever-evolving financial landscape,...

Continue Reading
Earnings Preview: What Investors Should Know About Coursera

Updated Category News Views 74

Understanding Coursera's Upcoming Earnings Report Coursera (NYSE: COUR) is set to release its quarterly earnings soon, and there is much anticipation surrounding this event. For investors looking to make informed decisions, understanding the key details and insights surrounding this announcement is crucial. Analysts are projecting an earnings per share (EPS) of $0.02, and...

Continue Reading
Quantum BioPharma Offers $7 Million Reward for Insider Tips

Updated Category News Views 189

Quantum BioPharma Announces Whistleblower Cash Reward Quantum BioPharma Ltd. (NASDAQ: QNTM) is making significant waves in the biopharmaceutical industry with its innovative strategy designed to combat stock manipulation. The company has launched a whistleblower policy that offers a remarkable cash reward of up to USD $7 million to those who provide concrete evidence...

Continue Reading